Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03630770|
Recruitment Status : Completed
First Posted : August 15, 2018
Results First Posted : June 14, 2022
Last Update Posted : June 14, 2022
|Condition or disease||Intervention/treatment||Phase|
|Candida Infection Premature Infant||Drug: Medium-Chain Triglyceride (MCT) Oil||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida|
|Actual Study Start Date :||June 5, 2014|
|Actual Primary Completion Date :||November 29, 2017|
|Actual Study Completion Date :||November 2, 2021|
No Intervention: Control
This group receives no feeding supplement.
Experimental: MCT Oil
This group is supplemented with MCT oil
Drug: Medium-Chain Triglyceride (MCT) Oil
Infants receive 0.5 ml/oz of MCT oil to their prescribed feedings for 21 days or until hospital discharge.
- Stool Fungal Burden [ Time Frame: Before supplementation, 1 week after supplementation begins, 3 weeks (at conclusion of supplementation) ]Change in colony-forming units (cfu) of Candida per gram of stool. Data table reflects total number of stool samples collected from subjects in each group that were included in the analysis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03630770
|United States, Rhode Island|
|Women & Infants Hospital of Rhode Island|
|Providence, Rhode Island, United States, 02905|
|Principal Investigator:||Joseph M Bliss, MD, PhD||Women and Infants Hospital of Rhode Island|